The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 08, 2020

Filed:

Mar. 28, 2019
Applicant:

The Government of the United States of America, As Represented BY the Secretary of Homeland Security, Washington, DC (US);

Inventors:

Michael Puckette, Waterford, CT (US);

Max V. Rasmussen, Guilford, CT (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 7/00 (2006.01); C07K 14/005 (2006.01); G01N 33/68 (2006.01); G01N 33/569 (2006.01); A61K 39/12 (2006.01); C07K 16/10 (2006.01); A61K 39/135 (2006.01); C12N 9/50 (2006.01); A61P 31/14 (2006.01); G01N 33/573 (2006.01);
U.S. Cl.
CPC ...
C12N 7/00 (2013.01); A61K 39/12 (2013.01); A61K 39/135 (2013.01); A61P 31/14 (2018.01); C07K 14/005 (2013.01); C07K 16/1009 (2013.01); C12N 9/506 (2013.01); C12Y 304/22028 (2013.01); G01N 33/56972 (2013.01); G01N 33/56983 (2013.01); G01N 33/573 (2013.01); G01N 33/6854 (2013.01); C12N 2770/32122 (2013.01); C12N 2770/32123 (2013.01); C12N 2770/32134 (2013.01); C12N 2770/32151 (2013.01); G01N 2333/09 (2013.01); G01N 2333/9513 (2013.01);
Abstract

This application is directed generally to foot-and-mouth disease virus (FMDV) 3C proteases that have been modified by mutating a polynucleotide sequence coding for the FMDV 3C protease. The modified FMDV proteases exhibit proteolytic activity on FMDV P1 precursor protein and exhibit a reduction in one or more toxic or inhibitory properties associated with an unmodified FMDV 3C protease on a host cell used to recombinantly produce it. Vectors carrying polynucleotides encoding modified FMDV 3C protease sequences can induce production of FMDV virus-like particles in a host cell when expressed in the host cell. The modified FMDV 3C proteases can generally be used to produce immunogenic FMDV preparations capable of inducing an immune response against FMDV.


Find Patent Forward Citations

Loading…